[{"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":151200000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":150100000.0,"RevenuesConverted_2_Q2_USD":5469000000.0,"RevenuesConverted_1_Q2_USD":2775000000.0,"Assets_0_Q2_USD":24470400000.0,"NetIncomeLossConverted_1_Q2_USD":1025500000.0,"StockholdersEquity_0_Q2_USD":10751900000.0,"EarningsPerShareDiluted_2_Q2_USD":5.68,"EarningsPerShareDiluted_1_Q2_USD":2.99,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":1996300000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":150800000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":149700000.0,"StockholdersEquityConverted_0_Q2_USD":11214800000.0,"NetIncomeLossConverted_2_Q2_USD":858700000.0,"EarningsPerShareBasic_1_Q2_USD":3.0,"EarningsPerShareBasic_2_Q2_USD":5.7,"Ticker":"BIIB","CIK":"875045","name":"BIOGEN INC.","OfficialName":"Biogen Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"32775642095.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20210722"}]